These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 4976364

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cell cultures for virus vaccine production. General conclusions from the conference.
    Merchant DJ.
    Natl Cancer Inst Monogr; 1968 Dec; 29():583-4. PubMed ID: 5720811
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Viral flora of tissue sources and tissue and medium antigens in vaccines--general comments.
    Jensen KE.
    Natl Cancer Inst Monogr; 1968 Dec; 29():207-8. PubMed ID: 5720793
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cell substrates for human virus vaccine preparation--general comments.
    Hayflick L.
    Natl Cancer Inst Monogr; 1968 Dec; 29():83-91. PubMed ID: 5720814
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Large-scale production of indefinitely propagated cell lines.
    Cooper PD.
    Natl Cancer Inst Monogr; 1968 Dec; 29():63-7. PubMed ID: 5720812
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Neoplastic properties of animal cell lines. Methods for determining neoplastic properties--discussion.
    Sandberg AA.
    Natl Cancer Inst Monogr; 1968 Dec; 29():233-6. PubMed ID: 5252583
    [No Abstract] [Full Text] [Related]

  • 35. Continuously propagated cell lines. Identification standards: serology.
    Brand KG.
    Natl Cancer Inst Monogr; 1968 Dec; 29():51-3. PubMed ID: 5720805
    [No Abstract] [Full Text] [Related]

  • 36. Cells, vaccines, and the pursuit of precedent.
    Hilleman MR.
    Natl Cancer Inst Monogr; 1968 Dec; 29():463-9. PubMed ID: 4888933
    [No Abstract] [Full Text] [Related]

  • 37. Comments on technology of production--continuous cell lines.
    Daniels WF.
    Natl Cancer Inst Monogr; 1968 Dec; 29():71-2. PubMed ID: 5720813
    [No Abstract] [Full Text] [Related]

  • 38. Blood group antigens in virus vaccines.
    Franks D, Dawson A.
    Natl Cancer Inst Monogr; 1968 Dec; 29():195-9. PubMed ID: 4888928
    [No Abstract] [Full Text] [Related]

  • 39. The need for a standardised cell substrate for virus vaccine production.
    Perkins FT.
    Ann Ist Super Sanita; 1969 Dec; 5(1):82-9. PubMed ID: 5382315
    [No Abstract] [Full Text] [Related]

  • 40. Characteristics of primary cultures and diploid cells--technology of production.
    Holper JC.
    Natl Cancer Inst Monogr; 1968 Dec; 29():21-31. PubMed ID: 4976359
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.